日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Correction: Targeted Inhibition of PDGFRA with avapritinib, markedly enhances lenvatinib efficacy in hepatocellular carcinoma in vitro and in vivo: clinical implications

更正：阿伐普利尼靶向抑制PDGFRA可显著增强乐伐替尼在体外和体内治疗肝细胞癌的疗效：临床意义

期刊:Journal of Experimental & Clinical Cancer Research
影响因子:12.8
doi:10.1186/s13046-025-03423-6
Zhao, Bixing; Zhou, Yang; Cheng, Niangmei; Zheng, Xiaoyuan; Chen, Geng; Qi, Xin; Zhang, Xiangzhi; Wang, Fei; Zhuang, Qiuyu; Assaraf, Yehuda G; Liu, Xiaolong; Wang, Yingchao; Zeng, Yongyi
细胞生物学
肿瘤
肿瘤免疫
PDGFRA
发表日期：2025
文献求助 收藏

Targeted inhibition of PDGFRA with avapritinib, markedly enhances lenvatinib efficacy in hepatocellular carcinoma in vitro and in vivo: clinical implications.

用阿伐替尼靶向抑制 PDGFRA，可显著增强乐伐替尼在体外和体内治疗肝细胞癌的疗效：临床意义

期刊:Journal of Experimental & Clinical Cancer Research
影响因子:12.8
doi:10.1186/s13046-025-03386-8
Zhao Bixing, Zhou Yang, Cheng Niangmei, Zheng Xiaoyuan, Chen Geng, Qi Xin, Zhang Xiangzhi, Wang Fei, Zhuang Qiuyu, Assaraf Yehuda G, Liu Xiaolong, Wang Yingchao, Zeng Yongyi
细胞生物学
肿瘤免疫
发表日期：2025
文献求助 收藏

Utilization of artificial circular RNAs as miRNA sponges and anti-PD-1 scFv expression platforms to suppress hepatocellular carcinoma progression.

利用人工环状RNA作为miRNA海绵和抗PD-1 scFv表达平台来抑制肝细胞癌的进展

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1609165
Lai Yongping, Wang Fei, Cai Guang, Li Yingying, Weng Jiaxin, Cai Feifan, Cai Leijie, Cheng Niangmei, Zhao Bixing, Zeng Yongyi
细胞生物学
miRNA
发表日期：2025
文献求助 收藏

Efficacy and safety of endovascular brachytherapy combined with transarterial chemoembolization for the treatment of hepatocellular carcinoma patients with type III or IV portal vein tumor thrombosis

血管内近距离放射治疗联合经动脉化疗栓塞术治疗伴有III型或IV型门静脉癌栓的肝细胞癌患者的疗效和安全性

期刊:World Journal of Surgical Oncology
影响因子:2.5
doi:10.1186/s12957-022-02495-4
Li, Ling; Cheng, Niangmei; Huang, Xinhui; Weng, Xiadi; Jiao, Yubin; Liu, Jingfeng; Guo, Wuhua
细胞生物学
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Development of Prognostic Evaluation Model to Predict the Overall Survival and Early Recurrence of Hepatocellular Carcinoma

建立预后评估模型以预测肝细胞癌患者的总生存期和早期复发

期刊:Journal of Hepatocellular Carcinoma
影响因子:3.4
doi:10.2147/JHC.S303330
Zhong, Yue; Yang, Yong; He, Lei; Zhou, Yang; Cheng, Niangmei; Chen, Geng; Zhao, Bixing; Wang, Yingchao; Wang, Gaoxiong; Liu, Xiaolong
细胞生物学
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏